% 100.00% 100.00% Cost of sales (90.36 ) (76.18 ) (14.18 ) 18.61% (74.35%) (69.32%) Gross Profit 31.17 33.72 (2.55 ) (7.56%) 25.65% 30.68% Other income 4.87 3.20 1.67 52.19% 4.01% 2.91% Distribution costs
% 141.84% Cost of sales (64.14) (90.36) 26.22 (29.02%) (74.86%) (105.46%) Gross Profit 21.54 31.17 (9.63) (30.90%) 25.14% 25.65% Other income 5.06 4.87 0.19 3.90% 5.91% 4.01% Distribution costs (17.79
%) 100.00% 148.40% Cost of sales (34.89 ) (48.06 ) 13.17 (27.41%) (76.73%) (105.71%) Gross Profit 10.58 19.41 (8.83 ) (45.50%) 23.27% 28.77% Other income 3.02 2.78 0.24 8.53% 6.64% 4.12% Distribution costs
revenues from services. As for the last year, the net profit of the Company of 7.34 million Baht. The cause of the details are as follows. Revenue For the six months period ended June 30, 2017 the Company
Plc. (“the Company”) would like to summarize it’s for the year 2017 operating performance for the period ending 31 December 2017 as follows: The Company and its subsidiaries’ posted a net profit of THB
resolution made on 22nd October 2019 approves residential property stimulus measures to support and ease the burden of those who wish to buy a home and to boost the domestic market sentiment. The transfer fee
Central Pattana Public Company Limited Management’s Discussion and Analysis (MD&A) Page 1 of 12 Executive Summary Growth in both revenue and net profit demonstrates the effectiveness of retail
mm or 32.4% from the same period of last year as the result of higher land transfer in 2017, compared to last year. Gross profit from sale of real estate stood at THB 1,639.9 mm during the year of 2017
Assets by Subsidiary of DOD Biotech Public Company Limited for the Purchase and Acceptance of Transfer of the Entire Business of BGP Spectrum Power Co., Ltd., and Establishment of Subsidiary, Classified as